About us
Our team
Careers
Bleepa®
How Bleepa® works
Benefits
Case studies
Feedback Connect
Service areas
Diagnostic-enhanced advice and guidance
Diagnostic enhanced advice and guidance and ERF payments
Clinical communication
Multi-disciplinary team working
Bleepa for cancer MDTs
MDT costs calculator
Private healthcare
Our capabilities
Safety & security
Integration & interoperability
Resources
News feed
Regulatory news (RNS)
Case studies
Resource hub
Investors
Regulatory news (RNS)
Share information
AIM Rule 26
Governance
Advisors
Contact
About us
Explore about us
Careers
Our team
Bleepa®
Explore Bleepa®
How Bleepa® works
Benefits
Case studies
Feedback Connect
Service areas
Explore service areas
Diagnostic-enhanced advice and guidance
Explore diagnostic-enhanced advice and guidance
Diagnostic enhanced advice and guidance and ERF payments
Clinical communication
Multi-disciplinary team working
Explore multi-disciplinary team working
Bleepa for cancer MDTs
MDT costs calculator
Private healthcare
Our capabilities
Explore our capabilities
Integration & interoperability
Safety & security
Resources
Explore Resources
News feed
Regulatory news (RNS)
Case studies
Resource hub
Investors
Explore investors
Regulatory news (RNS)
Share information
AIM Rule 26
Governance
Advisors
Contact
+44 (0) 20 3997 7634
sales@fbkmed.com
Get in
touch
News article
Interim results 2025
Date
26/02/2025
Posted by
Carrie Goldsworthy
Go Back
